Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking

Abstract

A novel strategy for anti-viral intervention of hepatitis B virus (HBV) through the disruption of the proper folding1 and transport2 of the hepadnavirus glycoproteins is described. Laboratory reared woodchucks chronically infected with woodchuck hepatitis virus (WHV) were treated with N-nonyl-deoxynojirimycin (N-nonyl-DNJ), an inhibitor of the endoplasmic reticulum (ER) α-glucosidases. The woodchucks experienced significant dose dependent decreases in enveloped WHV, resulting in undetectable amounts in some cases. The reduction in viremia correlated with the levels of hyperglucosylated glycan in the serum of treated animals. This correlation supports the mechanism of action associated with the drug and highlights the extreme sensitivity of the virus to this type of glycan inhibitor1,2. At N-nonyl-DNJ concentrations that prevented WHV secretion, the glycosylation of most serum glycoproteins appeared unaffected, suggesting great selectivity for this class of therapeutics. Indeed, this may account for the low toxicity of the compound over the treatment period. We provide the first evidence that glucosidase inhibitors can be used in vivo to alter specific steps in the N-linked glycosylation pathway and that this inhibition has anti-viral effects.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Mehta, A., Lu, X., Block, T.M., Blumberg, B.S. & Dwek, R.A. Hepatitis B virus envelope proteins vary drastically in their sensitivity to glycan processing. Proc. Natl. Acad. Sci. USA 94, 1822–1827 (1997).

    Article  CAS  Google Scholar 

  2. Lu, X. et al. Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited. Proc. Natl. Acad. Sci USA 94, 2380–2385 (1997).

    Article  CAS  Google Scholar 

  3. Sherker, A. & Marion, P. Hepadnaviruses and hepatocellular carcinoma. Ann Revs. Microb. 45, 475–508 (1991).

    Article  CAS  Google Scholar 

  4. Tipples, G.A. et al. Mutations in the HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24, 714–717 (1996).

    PubMed  CAS  Google Scholar 

  5. Tennant, B.C. & Gerin, J.L. The woodchuck model of hepatitis B virus infection. In: The Liver: Biology and pathobiology. 3rd edition. Eds. Aries, I.M. et al. Raven press, Publisher (NY, NY) pp. 1455–1466 (1994).

    Google Scholar 

  6. Hoofnagle, J.H. & DiBisceglie, A.M. Drug Therapy: The treatment of chronic viral hepatitis. New Engl. J. Med. 336, 347–356 (1997).

    Article  CAS  Google Scholar 

  7. Wong, D.C., Shi, J.W.K., Purcell, R.H., Gerin, J.L. & London, W.T. Natural and experimental infection of woodchucks with woodchuck hepatitis virus, as measured by new, specific assays for woodchuck hepatitis surface antigen and antibody. J. Clin. Microb. 15, 484–490 (1982).

    CAS  Google Scholar 

  8. Lu, X., Mehta, A., Butters, T., Dwek, R. & Block, T. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion. Virol. 213, 660–665 (1995).

    Article  CAS  Google Scholar 

  9. Cullen, J.M. et al. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethly)-1,3-oxathiolan-5-yl] cytosine in woodchuck hepatitis virus-infected woodchucks. Antimicro. Agents Chemo. 41, 2076–2082 (1997).

    Article  CAS  Google Scholar 

  10. Nowak, M.A. et al. Viral dynamics in hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 93, 4398–4402 (1996).

    Article  CAS  Google Scholar 

  11. Ueda, K., Tsurimoto, T. & Matsubara, K. Three Envelope Proteins of Hepatitis B virus: Large S, Middle S, and Major S needed for the formation of Dane particles J. Virol. 65, 3521–3529 (1991).

    PubMed  PubMed Central  CAS  Google Scholar 

  12. Seifer, M., Heermann, K.H. & Gerlich, W.J. Replication of hepatitis B virus in transfected nonhepatic cells. Virol. 179, 300–311 (1990).

    Article  CAS  Google Scholar 

  13. Wei, Y., Tavis, J.E. & Ganem, D. Relationship between viral DNA synthesis and virion envelopment in hepatitis B virus. J. Virol. 70, 6455–6458 (1997).

    Google Scholar 

  14. Abe, K., Kurata, T. & Shikata, T. Localization of woodchuck hepatitis virus in the liver. Hepatology 8, 88–92 (1988).

    Article  CAS  Google Scholar 

  15. Moore, S.E. & Spiro, R.G. Demonstration that Golgi endo—D-mannosidase provides a glucosidase independent pathway for the formation of complex N-linked oligosaccharides of glycoproteins. J. Biol. Chem. 265, 13104–13112 (1990).

    PubMed  CAS  Google Scholar 

  16. Werr, M. & Prange, R. Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles. J. Virol. 7, 778–782

  17. Jacob, G.S. Glycosylation inhibitors in biology and medicine. Curr. Opin Struct. Biol. 5, 605–611 (1995).

    Article  CAS  Google Scholar 

  18. Karpas, A. et al. Amino sugar derivatives as potential anti-HIV agents . Proc. Natl. Acad. Sci. USA 85, 9229–9233 (1988).

    Article  CAS  Google Scholar 

  19. Fontana, R.J. & Lok, A.S.F. Combination therapy for chronic hepatitis B. Hepatology 26, 234–236 (1997).

    Article  CAS  Google Scholar 

  20. Korba, A.B. et al. Liver-targeted antiviral nucleosides: Enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo . Hepatology 23, No.6 958–963 (1996).

    PubMed  CAS  Google Scholar 

  21. Lee, W.M. et al. Antibodies to polymerized albumin in woodchuck hepatitis virus infection. Viral Immuno. 6, 13–19 (1993).

    Article  CAS  Google Scholar 

  22. Guile, G.R., Rudd, P., Wing, D., Prime, S.B. & Dwek, R.A. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal. Biochem. 240, 210–226 (1996).

    Article  CAS  Google Scholar 

  23. Rudd, P.M. et al. Oligosaccharide Sequence Technology. Nature 388, 205–208 (1997).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Block, T., Lu, X., Mehta, A. et al. Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nat Med 4, 610–614 (1998). https://doi.org/10.1038/nm0598-610

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0598-610

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing